Membrane-tethered ligands are effective probes for exploring class B1 G protein-coupled receptor function

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 19, 2009, Pages 8049-8054

  Fortin, Jean Philippe ^a   Zhu, Yuantee ^a   Choi, Charles ^b   Beinborn, Martin ^a   Nitabach, Michael N ^b   Kopin, Alan S ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agonist; Antagonist; GPCR; Incretins; Peptide hormones

Indexed keywords

COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE;

BIOCHEMISTRY; CELL LINE; CELL MEMBRANE; GENE DELETION; HUMANS; INCRETINS; LIGANDS; MODELS, BIOLOGICAL; PEPTIDE HORMONES; PEPTIDES; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED;

MAMMALIA;

EID: 66049138465     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0900149106     Document Type: Article

References (31)

1. Lagerstrom MC, Schioth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7:339-357.
2. Hoare SR (2005) Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 10:417-427. (Pubitemid 40450272)
3. Pioszak AA, Xu HE (2008) Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci USA 105:5034-5039.
4. Pioszak AA, Parker NR, Suino-Powell K, Xu HE (2008) Molecular recognition of corticotropin- releasing factor by its G-protein-coupled receptor CRFR1. J Biol Chem 283:32900-32912.
5. Parthier C, et al. (2007) Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci USA 104:13942-13947. (Pubitemid 350003317)
6. Runge S, Thogersen H, Madsen K, Lau J, Rudolph R (2008) Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 283:11340-11347.
7. Green BD, Flatt PR (2007) Incretin hormone mimetics and analogues in diabetes therapeutics. Best Pract Res Clin Endocrinol Metab 21:497-516. (Pubitemid 350177567)
8. Doods H, Arndt K, Rudolf K, Just S (2007) CGRP antagonists: Unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28:580-587. (Pubitemid 350026615)
9. Mardini HE, de Villiers WJ (2008) Teduglutide in intestinal adaptation and repair: Light at the end of the tunnel. Expert Opin Investig Drugs 17:945-951.
10. Abad C, Gomariz RP, Waschek JA (2006) Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: Focus on VIP and PACAP. Curr Top Med Chem 6:151-163.
11. Arzt E, Holsboer F (2006) CRF signaling: Molecular specificity for drug targeting in the CNS. Trends Pharmacol Sci 27:531-538. (Pubitemid 44374761)
12. Chou KC, Elrod DW (1999) Prediction of membrane protein types and subcellular locations. Proteins 34:137-153. (Pubitemid 29019537)
13. Nielsen SM, Nielsen LZ, Hjorth SA, Perrin MH, Vale WW (2000) Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras. Proc Natl Acad Sci USA 97:10277-10281.
14. Neumann JM, et al. (2008) Class-B GPCR activation: Is ligand helix-capping the key? Trends Biochem Sci 33:314-319.
15. Wang X, Kaetzel MA, Yoo SE, Kim PS, Dedman JR (2002) Ligand-regulated secretion of recombinant annexin V from cultured thyroid epithelial cells. Am J Physiol Cell Physiol 282:C1313-C1321. (Pubitemid 34663080)
16. Al-Fulaij MA, Ren Y, Beinborn M, Kopin AS (2007) Identification of amino acid determinants of dopamine 2 receptor synthetic agonist function. J Pharmacol Exp Ther 321:298-307. (Pubitemid 46456991)
17. Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol Rev 53:1-24. (Pubitemid 32173106)
18. Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131-2157. (Pubitemid 46711096)
19. Xiao Q, et al. (2001) Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo. Biochemistry 40:2860-2869. (Pubitemid 32198288)
20. Adelhorst K, Hedegaard BB, Knudsen LB, Kirk O (1994) Structure-activity studies of glucagon-like peptide-1. J Biol Chem 269:6275-6278. (Pubitemid 24190992)
21. Hinke SA, et al. (2004) In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide. Life Sci 75:1857-1870. (Pubitemid 39070498)
22. Liapakis G, Chan WC, Papadokostaki M, Javitch JA (2004) Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the beta2 adrenergic receptor. Mol Pharmacol 65:1181-1190. (Pubitemid 38543488)
23. Montrose-Rafizadeh C, et al. (1997) High potency antagonists of the pancreatic glucagon-like peptide-1 receptor. J Biol Chem 272:21201-21206. (Pubitemid 27373982)
24. Luck MD, Carter PH, Gardella TJ (1999) The (1-14) fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors. Mol Endocrinol 13:670-680. (Pubitemid 30645321)
25. Beinborn M, Lee YM, McBride EW, Quinn SM, Kopin AS (1993) A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature 362:348-350. (Pubitemid 23101307)
26. Blaker M, et al. (1998) Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists. Mol Pharmacol 54:857-863.
27. Naim HY, Roth MG (1993) Basis for selective incorporation of glycoproteins into the influenza virus envelope. J Virol 67:4831-4841. (Pubitemid 23215964)
28. Poyner DR, et al. (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54:233-246. (Pubitemid 34575714)
29. Tibaduiza EC, Chen C, Beinborn M (2001) A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain. J Biol Chem 276:37787-37793. (Pubitemid 37384022)
30. Hearn MG, et al. (2002) A Drosophila dopamine 2-like receptor: Molecular characterization and identification of multiple alternatively spliced variants. Proc Natl Acad Sci USA 99:14554-14559. (Pubitemid 35257709)
31. Shinyama H, Masuzaki H, Fang H, Flier JS (2003) Regulation of melanocortin-4 receptor signaling: Agonist-mediated desensitization and internalization. Endocrinology 144:1301-1314. (Pubitemid 36428472)